ZHAOKE OPHTH-B(06622)
2.050-0.010-0.49%
Login to post
- CommunityCommunity
- NewsNews
- ProfileProfile
- AnnouncementsAnnouncements
- Retail investors in Zhaoke Ophthalmology Limited (HKG:6622) are its biggest bettors, and their bets paid off as stock gained 22% last weekRetail investors in Zhaoke Ophthalmology Limited (HKG:6622) are its biggest bettors, and their bets paid off as stock gained 22% last week
Simply Wall St. · 02-12
- Zhaoke Ophthalmology Procures Distributor for Presbyopia Drug in Australia, New ZealandZhaoke Ophthalmology Procures Distributor for Presbyopia Drug in Australia, New Zealand
MT Newswires Live · 01-13
- BRIEF-Zhaoke Ophthalmology Announces Distribution Agreement With AFT PharmaceuticalsBRIEF-Zhaoke Ophthalmology Announces Distribution Agreement With AFT Pharmaceuticals
Reuters · 01-13
- Zhaoke Ophthalmology Ltd - Entering Into Distribution- Agreement With AFT PharmaceuticalsZhaoke Ophthalmology Ltd - Entering Into Distribution- Agreement With AFT Pharmaceuticals
THOMSON REUTERS · 01-13
- Zhaoke Ophthalmology's Abbreviated NDA for Myopia Drug Accepted by Chinese RegulatorZhaoke Ophthalmology's Abbreviated NDA for Myopia Drug Accepted by Chinese Regulator
MT Newswires Live · 01-03
- BRIEF-Zhaoke Ophthalmology Says NMPA Acceptance Of New Drug Application For NVK002BRIEF-Zhaoke Ophthalmology Says NMPA Acceptance Of New Drug Application For NVK002
Reuters · 01-02
- Zhaoke Ophthalmology - Nmpa Acceptance of Abbreviated New Drug- Application for Nvk002 for Treatment of- Myopia Progression in ChildrenZhaoke Ophthalmology - Nmpa Acceptance of Abbreviated New Drug- Application for Nvk002 for Treatment of- Myopia Progression in Children
THOMSON REUTERS · 01-02
- Zhaoke Ophthalmology's Phase 3 Trial for Macular Degeneration Drug Meets Endpoints; Shares Rise 7%Zhaoke Ophthalmology's Phase 3 Trial for Macular Degeneration Drug Meets Endpoints; Shares Rise 7%
MT Newswires Live · 01-02
- Zhaoke Ophthalmology's Phase 3 Trial of Myopia Progression Drug Shows Positive ResultsZhaoke Ophthalmology's Phase 3 Trial of Myopia Progression Drug Shows Positive Results
MT Newswires Live · 2024-10-23
- Zhaoke Ophthalmology Completes Last Patient Visit for Trial of Macular Degeneration DrugZhaoke Ophthalmology Completes Last Patient Visit for Trial of Macular Degeneration Drug
MT Newswires Live · 2024-09-26
High
2.080
Open
2.050
Volume%
1.10
Low
2.000
Close
2.060
T/O Rate
0.27%
抱歉，当前请求异常(-1)
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email：uservice@ttm.financial